Healthcare

Medical technology firm Zynex is confronting a severe strategic crisis, prompting a dramatic shift in direction for its patient monitoring...

Wells Fargo delivered a surprising vote of confidence in Centene Corporation this Tuesday, dramatically raising its price target for the...

The investment case for telehealth provider Hims & Hers is facing increased scrutiny. Despite continuing to post robust growth, the...

The American healthcare conglomerate UnitedHealth is navigating its most challenging period in recent memory, implementing dramatic strategic changes to counter...

Investors in the telemedicine sector experienced a rollercoaster ride last week as Hims & Hers announced a significant restructuring of...

Johnson & Johnson is demonstrating remarkable momentum on dual fronts. The healthcare conglomerate's shares are approaching a fresh annual peak,...

A shareholder rebellion is creating additional turbulence for UnitedHealth Group as the healthcare conglomerate navigates multiple operational challenges. While contending...

The landscape of cancer diagnostics is undergoing a profound transformation, with Exact Sciences emerging as a pivotal innovator. The company's...

Cellectar Biosciences has achieved a critical regulatory milestone that could pave the way for European commercialization of its cancer therapeutic...

ImmunityBio finds itself at a pivotal moment, with groundbreaking clinical achievements coinciding with significant financial improvements. The biotechnology firm's recent...